BACK TO TOP
KSE100
166,419.71
233.55
(0.14%)
KSE100PR
49,895.73
63.00
(0.13%)
ALLSHR
100,871.91
48.64
(0.05%)
KSE30
49,316.65
23.11
(0.05%)
KMI30
239,907.59
-114.34
(-0.05%)
BKTI
45,849.28
104.46
(0.23%)
OGTI
33,523.01
-171.71
(-0.51%)
KMIALLSHR
65,473.68
-2.08
(0.00%)
PSXDIV20
76,053.59
295.78
(0.39%)
UPP9
59,580.20
53.11
(0.09%)
NITPGI
44,229.10
15.47
(0.03%)
NBPPGI
47,384.22
-28.86
(-0.06%)
MZNPI
30,011.17
-70.55
(-0.23%)
JSMFI
44,035.77
266.47
(0.61%)
ACI
21,305.08
11.08
(0.05%)
JSGBKTI
69,285.32
102.96
(0.15%)
HBLTTI
19,217.18
15-10-2026
0.09
(0.00%)
MII30
21,668.62
-4.39
(-0.02%)
Citi Pharma Ltd.
PHARMACEUTICALS
Rs.61.66
-0.38
(-0.61%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Oct 16, 2026 4:49 PM
REG
DFC
CSF
ODL
Open
62.04
High
62.39
Low
61.20
Volume
222,612
CIRCUIT BREAKER
55.84 — 68.24
DAY RANGE
61.20 — 62.39
52-WEEK RANGE ^
61.20 — 93.99
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
62.04
VAR
12.00
HAIRCUT
15.00
P/E Ratio (TTM) **
17.98
1-Year Change * ^
-33.68%
YTD Change * ^
-27.12%
Last update: Fri, Oct 16, 2026 4:36 PM
Open
62.12
High
62.36
Low
61.75
Close
62.02
Change
-0.53%
LDCP
62.35
Volume
41,000
Total Trades
41
CIRCUIT BREAKER
56.12 — 68.59
DAY RANGE
61.75 — 62.36
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 30, 2026 3:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
63.20
Volume
0
Total Trades
0
CIRCUIT BREAKER
56.88 — 69.52
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Sun, Aug 2, 2026 2:52 AM
Open
0.00
High
0.00
Low
0.00
Close
0.00
Change
0.00%
LDCP
62.45
Volume
0
Total Trades
0
CIRCUIT BREAKER
56.21 — 68.70
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Citi Pharma Limited was incorporated as a private limited company in Pakistan under the Repealed Companies Ordinance, 1984 on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The company was converted into public unlisted company with effect from October 13, 2020. The Company was listed on Pakistan Stock Exchange on July 09, 2021.

KEY PEOPLE
Rizwan AhmadCEO
Nadeem AmjadChairperson
Muhammad Rasheed AlamCompany Secretary
ADDRESS

3-KM, Head Balloki Road, Bhai Pheru, Distt Kasur

WEBSITE

www.citipharma.com.pk

REGISTRAR

F.D Registrar Services (Pvt.) Ltd.

AUDITOR

Aslam Malik & Co. Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
14,086,917.59
Shares
228,461,200
Free Float
114,230,600
Free Float
50.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 7, 2026Transmission of Annual Report for the Year Ended 30 June 2026 View   PDF
Oct 5, 2026Financial Results for the Year Ended 30 June 2026 View   PDF
Apr 30, 2026Transmission of Quarterly Report for the Period Ended 31st March 2026 View   PDF
Apr 30, 2026Financial Results for the Quarter Ended 31 March 2026 View   PDF
Feb 18, 2026Transmission of Quarterly Financial Statements for the Period Ended 2025-12-31 View   PDF
DateTitleDocument
Oct 7, 2026Notice of Annual General Meeting - Post Publication View   PDF
Oct 6, 2026Notice of Annual General Meeting (Prior to Publication) View   PDF
Sep 28, 2026Board Meeting View   PDF
Sep 18, 2026Certified Copy of the Resolutions Adopted in the Extraordinary General Meeting held on 18 September 2026 View   PDF
Aug 28, 2026Notice of Extraordinary General Meeting View   PDF
DateTitleDocument
Aug 10, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Aug 7, 2026Chief Financial Officer View   PDF
Jul 8, 2026Material Information View   PDF
May 21, 2026Material Information View   PDF
May 6, 2026Material Information View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales14,004,60813,153,52112,409,23912,396,983
Profit after Taxation782,597892,039833,464657,984
EPS3.433.903.652.88
Q3 2026Q2 2026Q1 2026Q3 2025
Sales3,084,7464,332,5663,370,2473,341,108
Profit after Taxation275,415404,334203,691220,375
EPS1.211.770.890.96
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)17.4915.3412.7812.16
Net Profit Margin (%)5.596.786.725.31
EPS Growth (%)(12.05)6.8526.74
PEG(1.88)3.140.29

Payouts

Financial Reports